Urinary brain-derived neurotrophic factor as a biomarker of executive functioning
Nancy S Koven1, Larisa R Collins
1Program in Neuroscience, Department of Psychology, Bates College, Lewiston, Maine, USA.
Neuropsychobiology
|June 20, 2014
Summary
Brain-derived neurotrophic factor (BDNF) levels are linked to cognitive flexibility in healthy adults. This study validates urinary BDNF as a peripheral biomarker for cognitive function.
Area of Science:
- Neuroscience
- Cognitive Science
- Genetics
Background:
- Neurotrophins, like brain-derived neurotrophic factor (BDNF), are crucial for neuronal health and plasticity.
- BDNF influences cognitive reserves, particularly within the prefrontal cortex.
- Individual differences in executive functions are partly explained by BDNF gene variations.
Purpose of the Study:
- To investigate the relationship between executive functioning and peripheral BDNF levels.
- To determine if in vivo neurochemistry, measured peripherally, correlates with cognitive abilities.
- To explore BDNF as a potential biomarker for cognitive function.
Main Methods:
- Fifty-two healthy young adults underwent a comprehensive executive function test battery.
- Urine samples were collected and analyzed for BDNF levels using enzyme-linked immunosorbent assay.
- BDNF concentrations were adjusted for creatinine levels.
Main Results:
- A positive association was found between BDNF concentration and cognitive flexibility.
- No significant relationship was observed between BDNF levels and working memory, abstract reasoning, response inhibition, or fluency.
- Urinary BDNF levels serve as a valid peripheral biomarker for cognitive function.
Conclusions:
- Cognitive flexibility is specifically associated with in vivo BDNF levels.
- Urinary BDNF is validated as a peripheral biomarker for assessing cognition in healthy adults.
More Related Videos
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
1.7K
06:22A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
Published on: September 3, 2021
2.7K
